sglt2 inhibitors and glp-1 receptor agonists Cardiovascular benefits of through effects on mitochondrial function and oxidative stress Combining GLP-1 Receptor Agonists and

Defining the appropriate dosage of MSC-Exos for therapeutic efficacy remains a key challenge, as standardized dosing regimens are yet to be established

First described in the mid-1990s, it is classified as a growth hormone secretagogue (GHS), a category of compounds designed to interact with the ghrelin/GHS receptor

Mol Neurobiol 61(9):66286641 Zeng J, Xie Z, Chen L, Peng X, Luan F, Hu J, Xie H, Liu R, et al

Nails: Brittle, slow-growing or peeling nails linked to nutritional deficiencies

We highlight the need for future research to identify the immunogenetic basis of severe or recurrent HSV disease in neonates and children